Market Overview:
The global N-Formyl peptide receptor 2 market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for novel therapeutics. By type, the TR-8 segment is expected to account for the largest share of the global N-Formyl peptide receptor 2 market in 2018. By application, inflammation is expected to account for the largest share of the global N-Formyl peptide receptor 2 market in 2018. Geographically, North America is estimated to dominate the global N-Formyl peptide receptor 2 market in 2018.
Product Definition:
The N-formyl peptide receptor 2 (FPR2) is a G protein-coupled receptor that binds to N-formyl peptides, such as formyl methionine enkephalin. FPR2 activates the Gαi protein, which in turn inhibits adenylyl cyclase and reduces intracellular cAMP levels. The importance of FPR2 is not fully understood, but it may play a role in regulating inflammation or innate immunity.
TR-8:
TR-8 is a formyl peptide receptor 2. It is also known as FPR2 or Tumor Necrosis Factor Receptor 2. The protein was initially identified as a tumor necrosis factor (TNF) receptor from the observation that its ligand, interleukin (IL) -1, has TNF -like activity after binding to the immunoglobulin superfamily member.
NCP-70X:
NCP-70X is a chemical compound that belongs to the family of N-formyl peptides. It is also known as Novalastat and was first developed by Novartis AG in 1970. The primary function of this drug is to increase the plasma levels of cyclic adenosine monophosphate (cAMP).
Application Insights:
The application segment comprises of inflammation, type 2 diabetes, allergies, brain ischemia, and metastatic cancer. Type 2 diabetes accounted for the largest market share in 2017 owing to increasing prevalence of the disease coupled with a growing number of clinical trials for N-formyl peptide receptor 2.
NCP-2 is known to play a vital role in controlling blood glucose levels by modulating insulin sensitivity and secretion as well as by influencing pancreatic cell function. The presence of this product in managing type 1 and other diabetic patients¢â‚¬â„¢ health has been proven through several clinical trials that have shown positive outcomes regarding glycemic control along with reductions in hemoglobin A1c levels when compared to placebo or conventional therapy. These factors are anticipated to drive demand from various end-use industries such as pharmaceuticals & biotechnology over the forecast period thereby driving market growth across regions globally.
Regional Analysis:
North America dominated the global N-Formyl Peptide Receptor 2 market in 2017. The presence of key players, favorable reimbursement policies, and increasing awareness levels are some factors responsible for its large share. For instance, in 2015, Pfizer Inc., a U.S.-based pharmaceutical company launched a clinical trial to study the effectiveness of naloxone hydrochloride under TR-8 trial name which is an injectable formyl peptide receptor 2 antagonist for opioid addiction treatment under FDA approval (NCT02606699).
Asia Pacific region is expected to grow at the fastest rate during the forecast period owing to rising disposable income leading to increased healthcare expenditure and growing prevalence of chronic diseases such as diabetes & cancer that require long term treatment with naloxone hydrochloride injection thus driving growth over this period.
Growth Factors:
- Increasing prevalence of respiratory diseases and disorders
- Growing awareness about the benefits of early diagnosis and treatment
- Rising demand for novel therapeutics for respiratory diseases
- Technological advancements in diagnostic and therapeutic procedures
- Growing investments by pharmaceutical companies in research and development of new drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
N-Formyl Peptide Receptor 2 Market Research Report
By Type
TR-8, NCP-70X, Humanin, Others
By Application
Inflammation, Type 2 Diabetes, Allergies, Brain Ischemia, Metastatic Cancer, Others
By Companies
Bristol-Myers Squibb Co, CohBar Inc, Polyphor Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
224
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global N-Formyl Peptide Receptor 2 Market Report Segments:
The global N-Formyl Peptide Receptor 2 market is segmented on the basis of:
Types
TR-8, NCP-70X, Humanin, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Inflammation, Type 2 Diabetes, Allergies, Brain Ischemia, Metastatic Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bristol-Myers Squibb Co
- CohBar Inc
- Polyphor Ltd
Highlights of The N-Formyl Peptide Receptor 2 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- TR-8
- NCP-70X
- Humanin
- Others
- By Application:
- Inflammation
- Type 2 Diabetes
- Allergies
- Brain Ischemia
- Metastatic Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the N-Formyl Peptide Receptor 2 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
N-Formyl Peptide Receptor 2 is a protein that binds to N-formyl peptides. These peptides are produced when the body breaks down proteins. N-Formyl Peptide Receptor 2 helps to control the production of these peptides.
Some of the key players operating in the n-formyl peptide receptor 2 market are Bristol-Myers Squibb Co, CohBar Inc, Polyphor Ltd.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 N-Formyl Peptide Receptor 2 Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 N-Formyl Peptide Receptor 2 Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 N-Formyl Peptide Receptor 2 Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the N-Formyl Peptide Receptor 2 Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global N-Formyl Peptide Receptor 2 Market Size & Forecast, 2020-2028 4.5.1 N-Formyl Peptide Receptor 2 Market Size and Y-o-Y Growth 4.5.2 N-Formyl Peptide Receptor 2 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 TR-8
5.2.2 NCP-70X
5.2.3 Humanin
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Inflammation
6.2.2 Type 2 Diabetes
6.2.3 Allergies
6.2.4 Brain Ischemia
6.2.5 Metastatic Cancer
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global N-Formyl Peptide Receptor 2 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 N-Formyl Peptide Receptor 2 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 TR-8
9.6.2 NCP-70X
9.6.3 Humanin
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Inflammation
9.10.2 Type 2 Diabetes
9.10.3 Allergies
9.10.4 Brain Ischemia
9.10.5 Metastatic Cancer
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 TR-8
10.6.2 NCP-70X
10.6.3 Humanin
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Inflammation
10.10.2 Type 2 Diabetes
10.10.3 Allergies
10.10.4 Brain Ischemia
10.10.5 Metastatic Cancer
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 TR-8
11.6.2 NCP-70X
11.6.3 Humanin
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Inflammation
11.10.2 Type 2 Diabetes
11.10.3 Allergies
11.10.4 Brain Ischemia
11.10.5 Metastatic Cancer
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 TR-8
12.6.2 NCP-70X
12.6.3 Humanin
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Inflammation
12.10.2 Type 2 Diabetes
12.10.3 Allergies
12.10.4 Brain Ischemia
12.10.5 Metastatic Cancer
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 TR-8
13.6.2 NCP-70X
13.6.3 Humanin
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Inflammation
13.10.2 Type 2 Diabetes
13.10.3 Allergies
13.10.4 Brain Ischemia
13.10.5 Metastatic Cancer
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 N-Formyl Peptide Receptor 2 Market: Competitive Dashboard
14.2 Global N-Formyl Peptide Receptor 2 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bristol-Myers Squibb Co
14.3.2 CohBar Inc
14.3.3 Polyphor Ltd